Intelligence · Clinical pipeline
Oncology R&D Pipeline
Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Quick answer
Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Top sponsors
- First People's Hospital 474 programs
- Chinese Academy of 400 programs
- United Therapeutics Europe 219 programs
- George Institute for 172 programs
- Takeda 163 programs
- HOFFMANN-LA ROCHE 144 programs
- AstraZeneca 143 programs
- MSD Merck Sharp 131 programs
- Regeneron UK 128 programs
- Anaxis Pharma 125 programs
- Telethon Foundation 113 programs
- Novartis India 110 programs
Pipeline programs
-
docetaxel
Sanofi Pasteur
Nasopharyngeal Neoplasms
1 trial -
docetaxel and ketoconazole
Hospital Authority, Hong Kong
Metastatic Breast Cancer
1 trial -
docetaxel+CDDP
Solid Biosciences
Head and Neck Squamous Cell Carcinoma
1 trial -
donor-derived NK cell infusion
Chongqing Precision Biotech Co., Ltd
Non-small Cell Lung Cancer
1 trial -
doxorubicin, docetaxel
Hospital Authority, Hong Kong
Metastatic Breast Cancer
1 trial -
entinostat
Syndax Pharmaceuticals
Epithelial Ovarian Cancer
1 trial -
entinostat
Syndax Pharmaceuticals
Estrogen Receptor-negative Breast Cancer
1 trial -
entinostat
Syndax Pharmaceuticals
Breast Cancer
4 trials -
eribulin mesylate + erlotinib
Eisai Co.,
Non-small Cell Lung Cancer
1 trial -
erlotinib [Tarceva]
Hoffmann-La Roche
Non-Small Cell Lung Cancer
1 trial -
erlotinib and bexarotene
LIGAND PHARMACEUTICALS INC
Carcinoma, Non-small-cell Lung
1 trial -
everolimus
United Therapeutics Europe Ltd
Malignant Peripheral Nerve Sheath Tumors
1 trial -
evorpacept
ALX ONCOLOGY HOLDINGS INC
Head and Neck Cancer
2 trials -
experimental group x-MAP
The First People's Hospital of Lianyungang
Metastatic Colorectal Cancer (mCRC)
1 trial -
farletuzumab ecteribulin
Bristol-Myers Squibb Australia Pty Ltd
Metastatic Non-Small Cell Lung Cancer
1 trial -
forodesine HCl
Biocryst
Chronic Lymphocytic Leukemia (CLL)
1 trial -
forodesine hydrochloride
Biocryst
Lymphoma
2 trials -
forodesine hydrochloride (BCX-1777)
Biocryst
Leukemia, T-Cell
1 trial -
forodesine hydrochloride (BCX-1777)
Biocryst
B-cell Acute Lymphoblastic Leukemia
1 trial -
forodesine hydrochloride (BCX-1777)
Biocryst
Leukemia, Lymphocytic, Chronic
1 trial -
fostamatinib
RIGEL PHARMACEUTICALS INC
Lymphoma
1 trial -
fruquintinib
Takeda
Colon Cancer
1 trial -
furmonertinib
Sun Yat-sen University
Non-small Cell Lung Cancer Metastatic
1 trial -
ganetespib
United Therapeutics Europe Ltd
Malignant Peripheral Nerve Sheath Tumors (MPNST)
1 trial -
gemcitabine
Yung NA
Muscle Invasive Bladder Urothelial Carcinoma
1 trial -
gemcitabine and cisplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Squamous Cell Carcinoma
1 trial -
gemcitabine and oxaliplatin.
The First People's Hospital of Lianyungang
Gallbladder Carcinoma
1 trial -
genexolPM + cisplatin
Solid Biosciences
Locally Advanced Head and Neck Squamous Cell Carcinoma
1 trial -
hyperbaric oxygen
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
imvotamab
ADC Therapeutics SA
Non-Hodgkin Lymphoma
1 trial -
indibulin
Alaunos Therapeutics
Advanced Solid Tumors
2 trials -
infusion of MYOCET
Teva Pharma GmbH
Cerebral Lymphoma B Cell Refractory
1 trial -
inhaled delta-8-THC 300mcg or 600mcg per dose
Teva Pharma GmbH
Cancer
1 trial -
interleukin-4 PE38KDEL cytotoxin
NEUROCRINE BIOSCIENCES INC
Brain and Central Nervous System Tumors
1 trial -
intravenous infusion (IV) of Adebrelimab (ADE)
The First People's Hospital of Lianyungang
Advanced Hepatocellular Carcinoma (HCC)
1 trial -
ipatasertib
United Therapeutics Europe Ltd
Solid Tumor
1 trial -
irradiation
Ultragenyx UK Limited
Brain Neoplasms
1 trial -
ivosidenib and nivolumab
Agios Netherlands B.V.
Advanced Solid Tumor
1 trial -
lenalidomide combined with rituximab
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial -
lurbinectedin for Advanced/Recurrent Endometrial…
The George Institute
Advanced/Recurrent Endometrial Cancer Patients with Disease Progression after Prior Therapy with Platinum-based Chemotherapy
1 trial -
lymphokine-activated killer cells
LISATA THERAPEUTICS, INC.
Brain and Central Nervous System Tumors
1 trial -
mFOLFOX6 + BIBF 1120
Galmed Pharmaceuticals
Colorectal Cancer
1 trial -
mFOLFOXIRI
The First People's Hospital of Lianyungang
Locally Advanced Rectal Cancer
1 trial -
mRNA-4157, BCG VACCINE
Merck Sharp and Dohme
Bladder cancer
1 trial -
megestrol acetate oral suspension + serplulimab + SOX
The First People's Hospital of Lianyungang
Stage III Gastric Cancer
1 trial -
mitoxantrone liposome 16 and azacitidine
NovaBridge Biosciences
Angioimmunoblastic T-cell Lymphoma
1 trial -
nab-paclitaxel
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
nal-IRI /Experimental
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Metastatic Gastric Adenocarcinoma
1 trial
Frequently asked questions
How many oncology pipeline programs are tracked?
5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.